Exits

We took two companies public and exited eight companies.
Year
Company/Description
Acquirer or Listing
Returns
2017

MitrAssist

Wai Tech (Hong Kong) Holding Ltd.
2.1X *
2017

BioSight

Cancer-targeted pharmaceuticals to release therapeutic drugs inside cancer cells
Arkin Bio Ventures LP
216.7 X
2016

E.T.View Medical

Continuous airway visualization during lung-isolation procedures
Ambu A/S
1.2 X
2014

Stimatix GI

B.Braun SAS
80.0 X(2)
2014

Inspiro Medical

Novel dry powder inhaler
OPKO Health Inc.
8.8 X
2013

InnoLap Surgical

Device for microlaparoscopic surgeries
Teleflex, Inc.
3.2 X
2013

FlowSense Medical

Accurate, real-time fluid (urine) monitoring
Baxter International Inc.
4.0 X
2011

PolyTouch Medical

Laparoscopic device for accurate, rapid hernia mesh deployment
Covidien Ltd.
6.7 X
2010

FlowSense Medical

Accurate, real-time fluid (urine) monitoring
IPO (3)
NA
2010

E.T.View Medical

Continuous airway visualization during lung-isolation procedures
IPO (3)
NA

Notes

  1. Estimated return represents the multiple of exit proceeds over Trendlines’ cash and non-cash investment in the exited company: (i) our cash investment and (ii) estimated value of services provided to the exited company.
  2. Exit by asset sale based on the fair value of Stimati GI (which remains in our portfolio) as of 31 December 2017, compared to our investment at that time.
  3. Reverse merger on the TASE